PT1122245E - 2-amino-benzoxazinonas para o tratamento de infeccoes virais - Google Patents

2-amino-benzoxazinonas para o tratamento de infeccoes virais

Info

Publication number
PT1122245E
PT1122245E PT01110048T PT01110048T PT1122245E PT 1122245 E PT1122245 E PT 1122245E PT 01110048 T PT01110048 T PT 01110048T PT 01110048 T PT01110048 T PT 01110048T PT 1122245 E PT1122245 E PT 1122245E
Authority
PT
Portugal
Prior art keywords
treatment
viral infections
benzoxazinones
amino
compounds
Prior art date
Application number
PT01110048T
Other languages
English (en)
Inventor
Clara I Villamil
Lori Ann Schretzman
Daniel P Becker
Roger A Nosal
John L Bedell
Kenneth Williams
Daniel L Flynn
Norman Abood
Brian M Bax
Hui Li
Michael J Bennett
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Priority claimed from US09/502,038 external-priority patent/US6380189B1/en
Publication of PT1122245E publication Critical patent/PT1122245E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT01110048T 1995-05-24 1996-05-23 2-amino-benzoxazinonas para o tratamento de infeccoes virais PT1122245E (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/448,795 US5985872A (en) 1995-05-24 1995-05-24 2-amino-benzoxazinones for the treatment of viral infections
US95262498A 1998-05-15 1998-05-15
US09/502,038 US6380189B1 (en) 1995-05-24 2000-02-11 2-amino benzoxazinones for the treatment of viral infections
US10/035,433 US6683077B2 (en) 1995-05-24 2002-01-04 2-Amino-benzoxazinones for the treatment of viral infections

Publications (1)

Publication Number Publication Date
PT1122245E true PT1122245E (pt) 2004-11-30

Family

ID=37772666

Family Applications (2)

Application Number Title Priority Date Filing Date
PT96914762T PT828721E (pt) 1995-05-24 1996-05-23 2-amino-benxoxazinonas para o tratamento de infeccoes virais
PT01110048T PT1122245E (pt) 1995-05-24 1996-05-23 2-amino-benzoxazinonas para o tratamento de infeccoes virais

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT96914762T PT828721E (pt) 1995-05-24 1996-05-23 2-amino-benxoxazinonas para o tratamento de infeccoes virais

Country Status (15)

Country Link
US (3) US5985872A (pt)
EP (1) EP0828721B1 (pt)
JP (1) JPH11505849A (pt)
CN (1) CN1070480C (pt)
AT (2) ATE270667T1 (pt)
AU (1) AU711174B2 (pt)
BR (1) BR9608506A (pt)
CA (1) CA2222034A1 (pt)
DE (2) DE69617005T2 (pt)
DK (1) DK0828721T3 (pt)
ES (2) ES2169242T3 (pt)
NZ (1) NZ308398A (pt)
PT (2) PT828721E (pt)
TW (1) TW455583B (pt)
WO (1) WO1996037485A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985872A (en) 1995-05-24 1999-11-16 G.D. Searle & Co. 2-amino-benzoxazinones for the treatment of viral infections
EP1122245B1 (en) * 1995-05-24 2004-07-07 G.D. Searle & Co. 2-Amino-benzoxazinones for the treatment of viral infections
AU3339797A (en) * 1996-06-20 1998-01-07 Smithkline Beecham Plc 4h-3,1-benzoxazin-4-one derivatives and analogs as antiviral agents
GB9710928D0 (en) * 1997-05-29 1997-07-23 Smithkline Beecham Plc Pharmaceuticals
GB9900416D0 (en) * 1999-01-08 1999-02-24 Alizyme Therapeutics Ltd Inhibitors
AR022204A1 (es) * 1999-01-08 2002-09-04 Norgine Bv Compuesto, proceso para su preparacion, composicion farmaceutica y producto comestible que lo comprende.
BR0012380A (pt) * 1999-07-12 2002-08-27 Searle & Co 2-amino-benzoxazinonas para o tratamento de vìrus do herpes simples
US6806269B1 (en) * 1999-07-12 2004-10-19 G. D. Searle & Cop 2-Amino-benzoxazinones for the treatment of herpes simplex virus
DE10036184A1 (de) * 2000-07-24 2002-02-14 Aventis Cropscience Gmbh Substituierte Sulfonylaminomethylbenzoesäure(derivate) und Verfahren zu ihrer Herstellung
WO2003002558A1 (fr) * 2001-06-13 2003-01-09 Asahi Kasei Pharma Corporation Remede pour maladies infectieuses virales
CN1714076A (zh) * 2002-11-21 2005-12-28 神经研究公司 芳基脲基衍生物及其医药用途
US7192471B2 (en) * 2004-09-24 2007-03-20 Honeywell International Inc. Aryl-ureido benzoxazinone compounds
ATE549321T1 (de) 2006-11-22 2012-03-15 Ajinomoto Kk Verfahren zur herstellung von phenylalaninderivaten mit chinazolindiongerüsten, und zwischenprodukte für die herstellung
EP2213655A1 (en) * 2007-04-27 2010-08-04 Paratek Pharmaceuticals, Inc. Methods For Purifying Aminoalkyl Tetracycline Compounds
US8356971B2 (en) * 2009-12-17 2013-01-22 Detch John W Disc turbine with streamlined hub vanes and co-axial exhaust tube
CN115109006A (zh) * 2022-05-20 2022-09-27 上海大学 一种3-取代-1,2-苯并噁嗪-4-酮类化合物及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3297755A (en) * 1960-12-02 1967-01-10 Hoffmann La Roche 2-chloro-5-trifluoromethylbenzo-phenone compounds
US3450700A (en) * 1966-12-20 1969-06-17 Upjohn Co 2-tertiary amino-4h-3,1-benzoxazin-4-ones
DE2218302A1 (de) * 1972-04-15 1973-10-25 Bayer Ag Verfahren zur herstellung von trifluormethylimino-derivaten von benzoxazinonen
DE2315303A1 (de) * 1973-03-27 1974-10-17 Bayer Ag Verfahren zur herstellung von n-substituierten 2-amino-3,1-benzoxazin-4-onen
US4657893A (en) * 1984-05-09 1987-04-14 Syntex (U.S.A.) Inc. 4H-3,1-benzoxazin-4-ones and related compounds and use as enzyme inhibitors
NZ210669A (en) * 1983-12-27 1988-05-30 Syntex Inc Benzoxazin-4-one derivatives and pharmaceutical compositions
US4745116A (en) * 1985-06-25 1988-05-17 Syntex (U.S.A.) Inc. 2-oxy-4H-3,1-benzoxazin-4-ones and related compounds and pharmaceutical use
US4665070A (en) * 1985-06-25 1987-05-12 Syntex (U.S.A.) Inc. 2-oxy-4H-3,1-benzoxazin-4-ones and pharmaceutical use
CA1309556C (en) * 1987-06-09 1992-10-27 Masayuki Kokubo 4h-3,1-benzoxazin-4-one compounds and pharmaceutical composition thereoffor the inhibition of serine proteases
EP0466944A4 (en) * 1990-02-15 1992-07-08 Teijin Limited 4h-3,1-benzoxazin-4-one compound and elastase inhibitor composition containing the same
CA2084997A1 (en) * 1991-04-10 1992-10-11 Koji Kobayashi Oxazinone derivative
NZ242739A (en) * 1991-05-24 1994-12-22 Arch Dev Corp Identification and purification of herpes protease nucleic acid segments and their use in the production of this protease
US5434074A (en) * 1991-07-05 1995-07-18 Gibson; D. Wade Cytomegalovirus proteinase
US5428021A (en) * 1994-01-27 1995-06-27 Sri International Human leukocyte elastase (HLE) inhibitors, and related pharmaceutical compositions and methods of use
US5652237A (en) * 1994-09-09 1997-07-29 Warner-Lambert Company 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes
EP1122245B1 (en) * 1995-05-24 2004-07-07 G.D. Searle & Co. 2-Amino-benzoxazinones for the treatment of viral infections
US5985872A (en) 1995-05-24 1999-11-16 G.D. Searle & Co. 2-amino-benzoxazinones for the treatment of viral infections

Also Published As

Publication number Publication date
DK0828721T3 (da) 2002-03-04
BR9608506A (pt) 1999-06-15
US5985872A (en) 1999-11-16
DE69617005D1 (de) 2001-12-20
JPH11505849A (ja) 1999-05-25
EP0828721B1 (en) 2001-11-14
ATE270667T1 (de) 2004-07-15
PT828721E (pt) 2002-04-29
CA2222034A1 (en) 1996-11-28
AU711174B2 (en) 1999-10-07
ES2169242T3 (es) 2002-07-01
DE69632876D1 (de) 2004-08-12
ES2225339T3 (es) 2005-03-16
AU5803096A (en) 1996-12-11
US20030022895A1 (en) 2003-01-30
EP0828721A1 (en) 1998-03-18
NZ308398A (en) 1999-06-29
CN1070480C (zh) 2001-09-05
ATE208765T1 (de) 2001-11-15
US20050032793A1 (en) 2005-02-10
CN1190963A (zh) 1998-08-19
DE69632876T2 (de) 2005-03-03
WO1996037485A1 (en) 1996-11-28
DE69617005T2 (de) 2002-07-04
TW455583B (en) 2001-09-21
US6683077B2 (en) 2004-01-27

Similar Documents

Publication Publication Date Title
PT828721E (pt) 2-amino-benxoxazinonas para o tratamento de infeccoes virais
DE69803907D1 (de) Fungizide 2-Methoxybenzophenone
EA200100412A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
ES2182234T3 (es) Inhibidores de metaloproteasa.
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
ATE206409T1 (de) N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h- benzo(b)(1,5)-diazepin-3-yl)-acetamide
ES2088537T3 (es) Derivados de piranil cianoguanidina.
EA199901016A1 (ru) 9-оксим-производные эритромицина
DK0903347T3 (da) Hidtil ukendte cyclodepsipeptid PF1022-derivater
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
ATE250021T1 (de) Hydroxycyclopentanone
ATE223226T1 (de) Azazyklohexapeptid-verbindungen
ES2155433T3 (es) Compuestos de 7-acil-3-(carbamoiloxi substituido) cefem, su utilizacion y procedimiento para su fabricacion.
MX9709016A (es) 2-amino-benzoxazinonas, composiciones que las contienen y uso de las mismas.
SE9602416D0 (sv) New forms of an organic salt of N'N-diacetylcystine
PT1140932E (pt) Derivados de 1,8-benzonaftiridina
PE64099A1 (es) Antibiotico derivado de cefalosporinas
GT199400033A (es) Compuestos antibacteriales (derivados de cefalosporina)